Company: Abbott Laboratories

(Reuters) - More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after a year of taking an experimental drug developed by Japan's Takeda Pharmaceutical Co, according to data from a pivotal late-stage trial.

India's Piramal Healthcare said Wednesday it will buy Decision Resources Group, a U.S. healthcare information company, for 34 billion rupees ($635 million), as it slowly taps its cashpile for overseas acquisitions.

Missouri will get more than $15 million from a national settlement with Abbott Laboratories involving the marketing of the drug Depakote.

Nebraska will receive nearly $5 million from Abbott Laboratories to settle concerns that it improperly marketed its anti-seizure drug Depakote.

Idaho will get $1.2 million as part of a multi-state settlement with Abbott Laboratories over illegal marketing of its anti-psychotic drug Depakote.

Iowa will receive more than $1.4 million from Abbott Laboratories to settle concerns that it improperly marketed its anti-seizure drug Depakote.

Attorney General Mike DeWine says Ohio will get more than $10.7 million for its share of a settlement between dozens of states and Abbott Laboratories.

Washington state will receive $7 million from multistate settlements with Abbott Laboratories over allegations the company illegally promoted an anti-seizure drug.

Utah will receive more than $4 million from a nationwide settlement with medical device and drugmaker Abbott Laboratories.

Rhode Island is set to receive more than $2.3 million from multistate settlements with Abbott Laboratories over allegations the company promoted the anti-seizure drug Depakote for uses that were not approved by the Food and Drug Administration.

The pharmaceuticals company agreed on Monday to pay $1.6 billion to resolve civil and criminal allegations related to past sales practices involving its anti-seizure drug Depakote.

The "Mad Money" host compiled a list of his favorite dividend-paying stocks. Read on to find out what they are.

Despite the recent stock pullback, corporate earnings are expected to continue giving the market some short-term momentum.

As investors and consumers watch them more closely, corporations are growing more conscious of their environmental and social behavior.

Investors are reassured – and companies consider it a point of pride – when executives note an uninterrupted track record for raising dividends. Dividend payments also offer investors a cushion on their investment, increasing the overall returns of the stock. Historically, dividend payments have accounted for more than 40 percent of the S&P 500’s total returns.